Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.
News: Patient Care
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Precision oncology expert Dr. Ben Ho Park sheds light on cancer treatment innovations.
The nature of childhood cancer is different than adult cancer, and so is the approach to treatment.
The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment.
The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers.
Immunotherapy is helping cancer patient Roszell Mack Jr. to continue going to his job on a Kentucky horse farm.
Customized oral stents can minimize harm from radiation therapy for some head and neck cancer patients.
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.
Vanderbilt Dermatology in collaboration with the Nashville Dermatology Society is offering free skin cancer screenings on Saturday, June 15, from 9 a.m. to noon at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane, Suite 26300.